[Differential diagnosis of congenital lipidoses by lipid analyses of body fluids, biopsy and autopsy tissue]
- PMID: 53174
[Differential diagnosis of congenital lipidoses by lipid analyses of body fluids, biopsy and autopsy tissue]
Abstract
1. Presentation of the commomly used procedures for the extraction and separation of total lipids, glycolipids and phosholipids from fresh and formalin-fixed organs tissues (brain, liver, spleen, kidney) as well as from serum, CSF and urine. II. Description of the qualitative and quantitative analysis of individual lipid fractions (glycolipids, gangliosides, phospholipids, neutral lipids) by thin-layer chromatograhy and photodensitometry. III. Results of investigations performed on biopsy material, autopsy material, serum and urine in the following diseases: 1. Infantile, juvenile and adult Gaucher's disease: accumulation of glucocerebroside in liver and spleen. 2. Infantile and adult Niemann-Pick disease: accumulation of sphingomyelin in liver, spleen, kidney and lung. 3. Fabry's disease: increased urinary excretion of trihexosyl-ceramide and dihexosyl-ceramide. 4. Infantile and adult metachromatic leukodystrophy: accumulation of sulfatides in the central and peripheral nervous system and kidney, increased urinary excretion of sulfatides. 5. Austin's variant of metachromatic leukodystrophy: besides an increase of sulfatides in the white matter of brain accumulation of glycolipids in the cerebral cortex. 6. Tay-Sachs disease (GM2-gangliosidosis): cerebral accumulation of GM2-ganglioside and trihexosylceramide (enzyme variant B), additional visceral accumulation (liver, spleen, kidney) of tetrahexosyl-ceramide = globoside (enzyme variant 0). 7. Infantile generalized GM1-gangliosidosis: cerebral (and visceral) accumulation of GM1-ganglioside and tetrahexosyl-ceramide. 8. Late infantile GM1-gangliosidosis: Cerebral accumulation of GM1-ganlioside and tetrahexosylceramide. 9. GM3-gangliosidosis (lactosyl-ceramidosis): neuronal accumulation of lactosyl-ceramide, GM2-ganglioside and GM3-ganglioside. 10. Refsum's disease: demonstration of phytanic acid esters of cholesterol in serum.
Similar articles
-
The lipidoses: morphologic changes in the nervous system in Gaucher's disease, GM2 gangliosidoses and Niemann-Pick disease.Ann Clin Lab Sci. 1975 Nov-Dec;5(6):475-88. Ann Clin Lab Sci. 1975. PMID: 812418
-
Accumulation of ganglioside Gm2 in cerebrospinal fluid of a patient with the variant AB of infantile Gm2 gangliosidosis.Pediatrics. 1981 Jul;68(1):106-8. Pediatrics. 1981. PMID: 7243492
-
Sphingolipidoses.Calif Med. 1971 Apr;114(4):1-6. Calif Med. 1971. PMID: 5551302 Free PMC article.
-
Enzymological approaches to the lipidoses.Ann Clin Lab Sci. 1977 Mar-Apr;7(2):105-12. Ann Clin Lab Sci. 1977. PMID: 403847 Review.
-
The liver in lipid storage disease: biochemical basis of pathogenesis and clinical features.Prog Liver Dis. 1982;7:331-46. Prog Liver Dis. 1982. PMID: 6810410 Review. No abstract available.
Cited by
-
Basic findings and current developments in sphingolipidoses.Hum Genet. 1979 Mar 12;47(2):113-34. doi: 10.1007/BF00273194. Hum Genet. 1979. PMID: 108196 Review.
-
Lysosome lipid storage disorder in NCTR-BALB/c mice: spleen and lung lysosomes store unesterified cholesterol but differ in their phospholipid composition.Mol Cell Biochem. 2000 Nov;214(1-2):15-22. doi: 10.1023/a:1007180800941. Mol Cell Biochem. 2000. PMID: 11195785
-
Late-onset metachromatic leukodystrophy: diagnostic problems elucidated by a case report.J Neurol. 1981;226(2):119-24. doi: 10.1007/BF00313439. J Neurol. 1981. PMID: 6186781